1Niu C,Yan H,Yu T,et al.Studies on treatment of acute promyelocytic leukemia with arsenic trioxide:remission indection,follow-up and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.Blood,1999,94:3315-24.
3Roberts TE,Sprague K,Schenkein D,et al.Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction[J].Blood,2000,96:4000-1.
4Camosino I,Lataglatia R,Avvisati G,et al.Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia[J].Haematologica,2004,89:615-7.
8Dai J,Weinberg RS,Waxman S,et al.Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system[J].Blood,1999,93:268-77.
9Karasavvas N,Stratis G,Golde DW,et al.Vitamin C protects HL60 and U266 cells from arsenic toxicity[J].Blood,2005,105:4004 -12.
10Yaguchi M,Miyazawa K,Katagiri T,et al.Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid[J].Leukemia,1997,11(6):779-87.
二级参考文献12
1Roberts TF, Sprague K, Schenkein D, et al. Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction. Blood, 2000, 96: 4000-4001.
2Camacho LH, Soignet SL, Chanel S, et al. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol, 2000, 18:2620-2625.
3Carmosino I, Latagliata R, Avvisati G, et al. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia. Haematologica, 2004,89:615-617.
4Wu MH, Smith SL, Dolan ME, et al. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells. Stem Cells, 2001, 19 : 492-499.
5ZhouJ,MengR,LiXX ,etal.TheeffectofarsenictrioxideonQTintervalprolongationduringAPLtherapy[].Chinese Medical Journal.2003
8Zhao WL,Chen SJ,Shen Y,et al.Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies[].Leukemia and Lymphoma.2001
9Wang ZY.Mechanism of action of all-trans retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia[].Gan To Kagaku Ryono.2002
10Rojewski M T,Baldus C,Knauf W,et al.Dual effects of arsenic trioxide (As2O3 ) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation[].British Journal of Haematology.2002
